Terms: = Sarcomas AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Diagnosis
132 results:
1. Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient.
Rogges E; Pelliccia S; Savio C; Lopez G; Della Starza I; La Verde G; Di Napoli A
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612584
[TBL] [Abstract] [Full Text] [Related]
2. Prognosis of children and young adults with newly diagnosed rhabdomyosarcoma metastatic to bone marrow treated on Children's Oncology Group studies.
Schloemer NJ; Xue W; Qumseya A; Luo LY; Hiniker SM; Lautz TB; Rhee DS; Arnold MA; Venkatramani R
Pediatr Blood Cancer; 2023 Dec; 70(12):e30701. PubMed ID: 37783659
[TBL] [Abstract] [Full Text] [Related]
3. A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with foxo1 fusion-positive rhabdomyosarcoma.
Freycon C; Lupo PJ; Witkowski L; Budd C; Foulkes WD; Goudie C
Pediatr Blood Cancer; 2023 Nov; 70(11):e30651. PubMed ID: 37638828
[TBL] [Abstract] [Full Text] [Related]
4. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract] [Full Text] [Related]
5. Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation.
Huang X; Li G; Li L; Wang J; Shen J; Chen Y; Yu W; Chen A; Wu T; Ma J; Ling B; He L; Chen X
Sci Rep; 2023 Mar; 13(1):4403. PubMed ID: 36928336
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features and prognosis of primary pulmonary rhabdomyosarcoma in middle-aged and elderly patients: a case report and literature review.
Xiaoxia J; Guihua Z; Jiatai W; Xinghua Z; Xudong C; Yingze W
J Int Med Res; 2023 Mar; 51(3):3000605231159782. PubMed ID: 36883437
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
[TBL] [Abstract] [Full Text] [Related]
8. PAX-foxo1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
[TBL] [Abstract] [Full Text] [Related]
9. Biphenotypic sinonasal sarcoma with PAX3/foxo1 fusion.
Tosun I; Karabulut MH; Yilmaz I; Cırık AA; Sahin O
Pol J Pathol; 2023; 74(4):282-285. PubMed ID: 38477090
[TBL] [Abstract] [Full Text] [Related]
10. Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report.
Mercolini F; Merks JHM; Minard-Colin V; Cameron A; van Scheltinga SEJT; Sher O; Fichera G; Orbach D; Glosli H; Coppadoro B; Gallego S; Chisholm JC; Bisogno G
Pediatr Blood Cancer; 2023 Mar; 70(3):e30143. PubMed ID: 36519598
[TBL] [Abstract] [Full Text] [Related]
11. Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.
Milewski D; Jung H; Brown GT; Liu Y; Somerville B; Lisle C; Ladanyi M; Rudzinski ER; Choo-Wosoba H; Barkauskas DA; Lo T; Hall D; Linardic CM; Wei JS; Chou HC; Skapek SX; Venkatramani R; Bode PK; Steinberg SM; Zaki G; Kuznetsov IB; Hawkins DS; Shern JF; Collins J; Khan J
Clin Cancer Res; 2023 Jan; 29(2):364-378. PubMed ID: 36346688
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
Ruhen O; Lak NSM; Stutterheim J; Danielli SG; Chicard M; Iddir Y; Saint-Charles A; Di Paolo V; Tombolan L; Gatz SA; Aladowicz E; Proszek P; Jamal S; Stankunaite R; Hughes D; Carter P; Izquierdo E; Wasti A; Chisholm JC; George SL; Pace E; Chesler L; Aerts I; Pierron G; Zaidi S; Delattre O; Surdez D; Kelsey A; Hubank M; Bonvini P; Bisogno G; Di Giannatale A; Schleiermacher G; Schäfer BW; Tytgat GAM; Shipley J
JCO Precis Oncol; 2022 Oct; 6():e2100534. PubMed ID: 36265118
[TBL] [Abstract] [Full Text] [Related]
13. A rare case of metastatic paraspinal rhabdomyosarcoma presenting with proptosis in an adult patient.
Chanda UL; Knapp C
Orbit; 2024 Apr; 43(2):280-282. PubMed ID: 36131600
[TBL] [Abstract] [Full Text] [Related]
14. Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.
Gallagher KPD; van Heerden W; Said-Al-Naief N; Carlos R; Arboleda LPA; Rodrigues-Fernandes CI; Araújo ALD; Fonseca FP; Pontes HAR; Innocentini LMAR; Romañach MJ; Vargas PA; Lopes MA; Santos-Silva AR; Khurram SA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Sep; 134(3):354-366. PubMed ID: 35840496
[TBL] [Abstract] [Full Text] [Related]
15. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
[TBL] [Abstract] [Full Text] [Related]
16. Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness.
Poli E; Barbon V; Lucchetta S; Cattelan M; Santoro L; Zin A; Milano GM; Zanetti I; Bisogno G; Bonvini P
Oncoimmunology; 2022; 11(1):2096349. PubMed ID: 35813575
[TBL] [Abstract] [Full Text] [Related]
17. Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS).
Stegmaier S; Sparber-Sauer M; Aakcha-Rudel E; Münch P; Reeh T; Feuchtgruber S; Hallmen E; Blattmann C; Bielack S; Klingebiel T; Koscielniak E
Pediatr Blood Cancer; 2022 Sep; 69(9):e29652. PubMed ID: 35338758
[TBL] [Abstract] [Full Text] [Related]
18. Adult Primary Pineal Alveolar Rhabdomyosarcoma with foxo1 Gene Rearrangement and OLIG2 Expression: A Rare Case Report and Literature Review.
Xie L; Wang W; Zhou H; Han Z; Xu J; Xu Z; Xiang J
Int J Surg Pathol; 2022 Oct; 30(7):769-775. PubMed ID: 35188829
[TBL] [Abstract] [Full Text] [Related]
19. An Integrative Morphologic and Molecular Approach for diagnosis and Subclassification of Rhabdomyosarcoma.
Fan R; Parham DM; Wang LL
Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261
[TBL] [Abstract] [Full Text] [Related]
20. Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel Cell Carcinoma.
Lindsey MS; Bridge JA; Douglas DS; Foster JT; Shalin SC; Gardner JM
Am J Dermatopathol; 2022 Mar; 44(3):218-222. PubMed ID: 34991098
[TBL] [Abstract] [Full Text] [Related]
[Next]
